1. Home
  2. XNCR vs MYE Comparison

XNCR vs MYE Comparison

Compare XNCR & MYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • MYE
  • Stock Information
  • Founded
  • XNCR 1997
  • MYE 1933
  • Country
  • XNCR United States
  • MYE United States
  • Employees
  • XNCR N/A
  • MYE N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • MYE Auto Parts:O.E.M.
  • Sector
  • XNCR Health Care
  • MYE Consumer Discretionary
  • Exchange
  • XNCR Nasdaq
  • MYE Nasdaq
  • Market Cap
  • XNCR 547.8M
  • MYE 598.2M
  • IPO Year
  • XNCR 2013
  • MYE N/A
  • Fundamental
  • Price
  • XNCR $8.62
  • MYE $15.90
  • Analyst Decision
  • XNCR Buy
  • MYE Buy
  • Analyst Count
  • XNCR 10
  • MYE 1
  • Target Price
  • XNCR $23.33
  • MYE $21.00
  • AVG Volume (30 Days)
  • XNCR 726.1K
  • MYE 217.5K
  • Earning Date
  • XNCR 11-05-2025
  • MYE 11-03-2025
  • Dividend Yield
  • XNCR N/A
  • MYE 3.36%
  • EPS Growth
  • XNCR N/A
  • MYE N/A
  • EPS
  • XNCR N/A
  • MYE 0.26
  • Revenue
  • XNCR $146,929,000.00
  • MYE $825,276,000.00
  • Revenue This Year
  • XNCR $22.06
  • MYE N/A
  • Revenue Next Year
  • XNCR N/A
  • MYE $1.94
  • P/E Ratio
  • XNCR N/A
  • MYE $61.57
  • Revenue Growth
  • XNCR N/A
  • MYE 1.11
  • 52 Week Low
  • XNCR $6.92
  • MYE $9.06
  • 52 Week High
  • XNCR $27.24
  • MYE $17.12
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 55.91
  • MYE 46.48
  • Support Level
  • XNCR $8.25
  • MYE $15.83
  • Resistance Level
  • XNCR $8.73
  • MYE $16.89
  • Average True Range (ATR)
  • XNCR 0.37
  • MYE 0.41
  • MACD
  • XNCR 0.06
  • MYE -0.12
  • Stochastic Oscillator
  • XNCR 69.03
  • MYE 7.75

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About MYE Myers Industries Inc.

Myers Industries Inc designs, manufactures, and markets a variety of plastic, metal, and rubber products, including a broad selection of plastic reusable containers, pallets, small parts bins, bulk shipping containers, storage and organization products, OEM parts, custom plastic products, consumer fuel containers and tanks for water, fuel and waste handling. It operates through the following segments: The Material Handling segment manufactures a selection of durable plastic reusable products that are used repeatedly during the course of their service life. The Distribution segment is engaged in the distribution of equipment, tools, and supplies used for tire servicing and automotive under-vehicle repair, etc. It generates the majority of its revenue from the Material Handling segment.

Share on Social Networks: